Defense biotech building Argus, an automated air sampler that sequences DNA on-board to detect airborne pathogens
Pilgrim is a Redwood City, CA defense-biotech startup founded by Thiel Fellow Jake Adler. Its flagship Argus is a 50-pound unit that continuously samples air and runs genomic sequencing on board to detect pathogens such as Ebola and anthrax, aimed at airports, transit hubs and military sites. The company has an agreement with the US CDC to build an automated airborne biosurveillance system and has begun deploying Argus units; contract size and unit counts are undisclosed. On 2026-09-23 the WSJ reported a $25M seed led by Buckley Ventures at a $150M valuation, with Peter Thiel, Fred Ehrsam and Anthropic staff Logan Graham and Sholto Douglas participating. Pilgrim previously raised a $3.25M pre-seed and a $4.3M seed led by Cantos in 2025, and also develops the Kingsfoil wound dressing and the Voyager inhaled countermeasure.
Defense📍 Redwood City, CAFounded 2024
Current Valuation
$150M
as of 2026-09-23
PRIVATE
QL Price
$150M
0% vs last round
QuantLogix's current estimate for Pilgrim, published 2026-09-25 — in line with the last disclosed round of $150M (2026-09-23).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$150M
2026-09-23
weight 1
How this price has held up
No round has priced for Pilgrim since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-25 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Pilgrim, 2026-09-25 (f7b36b86611714af).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Pilgrim going public?
No. Pilgrim is private and has not filed to go public. There is no S-1 on file.
What is Pilgrim's valuation in 2026?
Pilgrim is valued at $150M as of 09/23/2026, set by its Seed ($25M, Sep 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Pilgrim filed an S-1?
No public S-1 is on file for Pilgrim.
Who are Pilgrim's investors?
Pilgrim's investors include Buckley Ventures, Peter Thiel / Thiel Capital, Cantos, Refactor Capital, Day One Ventures, Fred Ehrsam.
How much has Pilgrim raised?
Pilgrim has raised $32.55M in total across 3 disclosed rounds, most recently a Seed of $25M in Sep 2026.
Is Pilgrim publicly traded — can you buy Pilgrim stock?
No. Pilgrim is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Pilgrim on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Jake Adler
Founded
2024
HQ
Redwood City, CA
Total Raised
$32.55M
Growth
Agreement with the US CDC to build an automated airborne biosurveillance system; Argus deployments under way (Sept 2026)
Last Round
Seed — $25M (Sep 2026) · Lead: Buckley Ventures
IPO Status
private
Fundraising Status
Seed · $25M · this month
privateTotal raised $32.55M3 disclosed rounds
Seed Impact
Round Size
$25M
Primary financing announced
Post-Money Valuation
$150M
Company-announced mark
Round / Post-Money
16.7%
New capital ÷ post-money
Disclosed Funding
$32.55M
Cumulative disclosed rounds
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.
Growth & Valuation
Capital raised per round
Charts built from publicly disclosed funding rounds and revenue estimates. Approximate, not real-time, not investment advice.
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Seed
$25M
Sep 2026
Buckley Ventures
$150M
Pre-seed
$3.25M
Mar 2025
Peter Thiel; Cantos; Refactor Capital
—
Seed
$4.3M
Jan 2025
Cantos
—
Vertical Intelligence — Defense / Aerospace
Defense / Aerospace registry data for Pilgrim has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for Pilgrim has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
Founders & Key People
Jake Adler
Investors
Buckley Ventures · Peter Thiel / Thiel Capital · Cantos · Refactor Capital · Day One Ventures · Fred Ehrsam
Products
Argus (airborne pathogen detection)
Kingsfoil (hemostatic dressing)
Voyager (inhaled chemical countermeasure)
Defense TechBiodefenseBiosecurityGenomicsHardware
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-09-23. Refreshed quarterly.